1. Sanofi, R&D Preclinical Safety Frankfurt, Industriepark Höchst, Frankfurt am Main, Germany
2. Gilead Sciences, Nonclinical Safety and Pathobiology, Foster City, CA, USA
3. Leadscope, Inc., Columbus, OH, USA
4. Bristol-Myers Squibb, Drug Safety Evaluation, New Brunswick, NJ, USA
5. GlaxoSmithKline Pre-Clinical Development, Ware, Hertfordshire, UK
6. Genentech, Inc., Safety Assessment, South San Francisco, CA, USA
7. National Institute of Health Sciences, Division of Genetics & Mutagenesis, Kamiyoga, Setagaya-ku, Tokyo, Japan
8. Toxicology Division, Eli Lilly and Company, Indianapolis, IN, USA
9. Pfizer Worldwide Research and Development, Drug Safety, Genetic Toxicology, Groton, CT, USA
10. U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA
11. Xiphora Biopharma Consulting, Bristol, UK
12. AstraZeneca, Pharmaceutical Technology and Development, Macclesfield, Cheshire, UK
13. Bayer AG, Pharmaceuticals Division, Investigational Toxicology, Muellerstr, Berlin, Germany